Tectonic Advisors LLC Sells 184 Shares of Encompass Health Co. (NYSE:EHC)

Tectonic Advisors LLC cut its stake in Encompass Health Co. (NYSE:EHC) by 2.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 6,152 shares of the company’s stock after selling 184 shares during the quarter. Tectonic Advisors LLC’s holdings in Encompass Health were worth $568,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the company. MassMutual Private Wealth & Trust FSB increased its stake in Encompass Health by 87.8% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock valued at $27,000 after purchasing an additional 137 shares in the last quarter. UMB Bank n.a. grew its holdings in shares of Encompass Health by 387.7% in the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company’s stock valued at $31,000 after buying an additional 252 shares during the period. V Square Quantitative Management LLC increased its position in shares of Encompass Health by 53.0% in the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock valued at $39,000 after buying an additional 140 shares in the last quarter. Avior Wealth Management LLC acquired a new stake in Encompass Health during the 3rd quarter worth $40,000. Finally, Tompkins Financial Corp bought a new position in Encompass Health during the fourth quarter worth about $46,000. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Encompass Health Trading Up 1.0 %

Shares of NYSE:EHC opened at $102.18 on Thursday. The stock has a market capitalization of $10.29 billion, a PE ratio of 24.68, a price-to-earnings-growth ratio of 1.18 and a beta of 0.90. The company’s 50-day moving average price is $96.43 and its two-hundred day moving average price is $95.08. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04. Encompass Health Co. has a one year low of $71.79 and a one year high of $104.55.

Analyst Ratings Changes

A number of equities research analysts have recently commented on EHC shares. Truist Financial reaffirmed a “buy” rating and set a $116.00 price target (up previously from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. Barclays raised their target price on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. Royal Bank of Canada increased their price objective on shares of Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. Finally, KeyCorp boosted their price objective on shares of Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a research report on Tuesday, October 29th. Nine analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Buy” and an average price target of $107.11.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.